IP Verse

Syringe

Patent No. EP3858405 (titled "Syringe") was filed by Novartis on May 30, 2013. The application was issued on Apr 5, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJan 5, 2024ELKINGTON AND FIFE
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBJun 29, 2023KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3858405

NOVARTIS
Application Number
EP21164847A
Filing Date
May 30, 2013
Status
Granted And Under Opposition
Mar 3, 2023
Publication Date
Apr 5, 2023
External Links
Slate, Register , Google Patents